This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
APO-AMOXI PWR FOR SUSP 125MG/5ML (2017-08-18)
- Starting date:
- August 18, 2017
- Posting date:
- August 30, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-64352
Reason
The impurities are out of specification in lot MT7669. The impurities are out of trend in lot MW9537.
Depth of distribution
Wholesalers, retailers, pharmacies: Ontario, Quebec, New Brunswick, British Columbia, Alberta, Newfoundland, Saskatchewan, Manitoba, Nova Scotia
Affected products
APO-AMOXI PWR FOR SUSP 125MG/5ML
DIN, NPN, DIN-HIM
DIN 00628131
Dosage form
Powder For Suspension
Strength
125 mg / mL
Lot or serial number
(L) MT7669
(L) MW9537
Companies
- Recalling Firm
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
- Marketing Authorization Holder
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA